Matches in Nanopublications for { ?s ?p "[Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1260346.RAUCJabokox4T81ZO68SyNYqa9yOx5Rbi0WBsXjiKqs54130_assertion description "[Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260346.RAUCJabokox4T81ZO68SyNYqa9yOx5Rbi0WBsXjiKqs54130_provenance.
- NP1260347.RAudnA9P3KIhwJQhmO7BiGWUemQqT0IViQTT7RNnWv7DY130_assertion description "[Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260347.RAudnA9P3KIhwJQhmO7BiGWUemQqT0IViQTT7RNnWv7DY130_provenance.